Vaccines

Following the green light from the vaccine advisory committee, the US Food and Drug Administration has given emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, making it the first vaccine for COVID-19 approved for use in the United States.

The US Food and Drug Administration (FDA) vaccine committee has given the green light to the the Pfizer/BioNTech vaccine, meaning approval may happen in a matter of days.

The United States has been working on increasing human papillomavirus (HPV) vaccine coverage, with many potential interventions suggested. Are these interventions both effective and cost-effective?

The hepatitis B vaccine represents the best way to prevent the disease, which has no cure. An investigation looks at how long vaccine-linked immunity might last.

Vaccine hesitancy has led to reductions in many childhood vaccines. A report offers insight into how it impacts influenza vaccination.

Pfizer and BioNTech have released interim information on their Phase 3 COVID-19 vaccine trial.

With a rise in vaccine hesitancy, it’s more important than ever to have strong vaccine adherence. A poster at the virtual 2020 ID Week looks at how vaccine type can impact diphtheria, tetanus, and acellular pertussis (DTaP) vaccination.

The influenza vaccine has been recommended as a key way to reduce severe influenza in children. An investigation examines how effective the 2018-2019 vaccine was in preventing hospitalization and emergency department visits.

We may have grown used to chemicals being a part of everyday life, but some will cause many parents to worry. A presentation at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition offers guidance on how to address these concerns.

Human papillomavirus (HPV) vaccination coverage has lagged in the United States. A report looks at whether the coverage will meet the Healthy People 2020 goal.

Dr. Tina Tan addresses the recent change that allows pharmacists to administer vaccinations to pediatric patients.

The 2020-2021 influenza season is fast approaching and the American Academy of Pediatrics (AAP) has issued their annual recommendations.

This is the critical moment in time for all health care providers to proactively stop this potential public health nightmare by speaking with all parents and adolescents about the absolute need for everyone to receive the influenza vaccine.

The US government has entered into an agreement to acquire the first 100 doses of a COVID-19 vaccine candidate developed by Moderna, Inc., pending approval by the US Food and Drug Administration.

As the COVID-19 pandemic continues, a new question arises: should schools with in-person classes require students and their family to get the flu vaccine?

A study looks at whether a vaccine for respiratory syncytial virus (RSV) could be effective in reducing RSV-associated, medically significant lower respiratory tract infections in infants.

Three scientists discuss the global race for a COVID-19 vaccine.

A program with the goal of expanding human papillomavirus (HPV) vaccination and preventing HPV-related cancers has been expanded.

A recent study offers hope for more effective vaccine responses.

Immunizations during pregnancy are common and meant to provide protection during the early months of life. A literature review looks at whether the practice influences other early health outcomes.

The US government has entered into an agreement to acquire the first 100 doses of a COVID-19 vaccine candidate developed by Pfizer and BioNTech, pending approval by the US Food and Drug Administration.

Routine vaccination for meningococcal disease has been recommended since 2005. A study looks at whether the recommendation has reduced the incidence of disease.

Walgreens announces that routine immunization service will resume.

Initiation and completion rates for human papillomavirus (HPV) vaccine aren’t where public health officials would like them to be. A report examines whether an intensive intervention can help improve those rates.

Vaccine hesitancy is a major issue in pediatrics and many have wondered how prevalent the issue is. A new survey offers a dispiriting answer.

Active, healthy 11-y/o boy develops degenerative neurologic symptoms. PMH relevant for measles at age 1 year, MMR vaccine at 8 months. Is there a connection?

In the absence of an official preference for one formulation over another, we can do what's best for our patients.

A seasoned pediatrician learns something new after a mother offers a moral defense against the Varivax vaccine for her son.

There is no room in the office refrigerator for Monday's vaccine delivery. Your son's mini-fridge is an ideal temporary fix. True or False?

The mother of a 12-year-old boy resists your suggestion that he receive the HPV4 vaccine today. She asks three good questions. Do you know the answers?